These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31474987)

  • 1. Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.
    Yasamut U; Thongkum W; Moonmuang S; Sakkhachornphop S; Chaiwarith R; Praparattanapan J; Wipasa J; Chawansuntati K; Supparatpinyo K; Lai E; Tayapiwatana C
    Front Immunol; 2019; 10():1905. PubMed ID: 31474987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms.
    Ramberger M; Berretta A; Tan JMM; Sun B; Michael S; Yeo T; Theorell J; Bashford-Rogers R; Paneva S; O'Dowd V; Dedi N; Topia S; Griffin R; Ramirez-Franco J; El Far O; Baulac S; Leite MI; Sen A; Jeans A; McMillan D; Marshall D; Anthony D; Lightwood D; Waters P; Irani SR
    Brain; 2020 Jun; 143(6):1731-1745. PubMed ID: 32437528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of Bortezomib for Treating Anti-Interferon-Gamma Autoantibody-Associated Adult-Onset Immunodeficiency Syndrome.
    Angkasekwinai N; Suputtamongkol Y; Tantibhedhyangkul W; Onlamoon N; Phoompoung P; Pithukpakorn M; Karuphong E; Pusuwan P; Angkasekwinai P
    Clin Infect Dis; 2024 Apr; 78(4):1033-1042. PubMed ID: 37947190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative immunohistochemical analysis of inflammatory cytokines in distinct subtypes of Sweet syndrome.
    Chieosilapatham P; Daroontum T; Suwansirikul S; Chaiwarith R; Phinyo P; Chaowattanapanit S; Choonhakarn C; Kiratikanon S; Rujiwetpongstorn R; Tovanabutra N; Chiewchanvit S; Chuamanochan M
    Front Immunol; 2024; 15():1355681. PubMed ID: 38529275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Adult-onset immunodeficiency mediated by anti-IFN-γ autoantibody combined with disseminated mycobacterium marseillense infection: a case report].
    Liu JJ; Qin L; Cong Y; Liu HT; Fan JP; Fan HW; Zhou BT; Cao W
    Zhonghua Nei Ke Za Zhi; 2024 Aug; 63(8):795-799. PubMed ID: 39069870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical manifestations of cutaneous findings in patients with adult-onset immunodeficiency due to anti-interferon gamma autoantibodies: an eight-year retrospective study.
    Pattanaprichakul P; Leeyaphan C; Angkasekwinai N; Bunyaratavej S; Senawong S; Sereeaphinan C; Munprom K
    Int J Dermatol; 2023 Dec; 62(12):1506-1510. PubMed ID: 37828737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tolerance precedes triggering and lifelong persistence of pathogenic type I interferon autoantibodies.
    Fernbach S; Mair NK; Abela IA; Groen K; Kuratli R; Lork M; Thorball CW; Bernasconi E; Filippidis P; Leuzinger K; Notter J; Rauch A; Hirsch HH; Huber M; Günthard HF; Fellay J; Kouyos RD; Hale BG;
    J Exp Med; 2024 Sep; 221(9):. PubMed ID: 39017930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
    Cohen JM; Damsky W
    N Engl J Med; 2024 Jul; 391(2):188-189. PubMed ID: 38986070
    [No Abstract]   [Full Text] [Related]  

  • 9. Anti-Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency.
    Cheng A; Kashyap A; Salvator H; Rosen LB; Colby D; Ardeshir-Larijani F; Loehrer PJ; Ding L; Lugo Reyes SO; Riminton S; Ballman M; Rocco JM; Marciano BE; Freeman AF; Browne SK; Hsu AP; Zelazny A; Rajan A; Sereti I; Zerbe CS; Lionakis MS; Holland SM
    N Engl J Med; 2024 Mar; 390(12):1105-1117. PubMed ID: 38507753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cytokine autoantibodies in autoimmune diseases.
    Cappellano G; Orilieri E; Woldetsadik AD; Boggio E; Soluri MF; Comi C; Sblattero D; Chiocchetti A; Dianzani U
    Am J Clin Exp Immunol; 2012; 1(2):136-46. PubMed ID: 23885320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health related quality of life in anti interferon γ autoantibody associated immunodeficiency syndrome measured with EQ5D5L and SF36.
    Temsangsukmanee J; Laisuan W; Thadanipon K; Pisitkun P; Ngamjanyaporn P; Suangtamai T; Oncham S; Chantharit P; Rotjanapan P
    Sci Rep; 2023 Sep; 13(1):14346. PubMed ID: 37658088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An easy assay to detect autoantibodies neutralizing cytokines in subjects with critical infections.
    Donadel N; Tesser A; Valencic E; De Martino E; Boz V; Pin A; Zorat F; Pozzato G; Tommasini A
    J Immunol Methods; 2024 Jul; 530():113696. PubMed ID: 38797274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A homogeneous bioluminescent inhibition immunoassay to detect anti-interferon gamma antibodies.
    Bradhurst P; Stoyanov A; Nithichanon A; Bundell C; Urriola N
    Clin Exp Immunol; 2024 Jul; ():. PubMed ID: 38975719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Neutralizing Autoantibodies Against Type I Interferon in a Multicenter Cohort of Severe or Critical COVID-19 Cases in Shanghai.
    Shi D; Chen J; Zhao M; Tang Y; Zhao C; Jin Y; Tian D; Liao Y; Wang X; Wang W; Fan X; Yi Z; Chen X; Ling Y
    J Clin Immunol; 2024 Mar; 44(3):80. PubMed ID: 38462559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D levels in non-pregnant women with a history of recurrent pregnancy loss with and without autoantibodies.
    Farazmand T; Rahbarian R; Jalali M; Ghahremani A; Razi A; Namdar Ahmadabad H
    Caspian J Intern Med; 2024; 15(2):266-272. PubMed ID: 38807736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-α2 Autoantibody Screening and Functional Evaluation in Viral and Bacterial Infections.
    Cockx M; Steels S; Michiels B; Van Elslande J; Vermeersch P; Frans G; Claeys KG; Desmet S; De Munter P; Bossuyt X
    J Appl Lab Med; 2024 Aug; ():. PubMed ID: 39114898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon autoantibodies as signals of a sick thymus.
    Oftedal BE; Sjøgren T; Wolff ASB
    Front Immunol; 2024; 15():1327784. PubMed ID: 38455040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Anti-Interferon
    Fink DL; Idilli O; Shields A; Richter A; Burns SO
    J Clin Immunol; 2024 Jul; 44(7):161. PubMed ID: 38990439
    [No Abstract]   [Full Text] [Related]  

  • 19. Neutralizing Autoantibodies against Interleukin-10 in Inflammatory Bowel Disease.
    Griffin H; Ceron-Gutierrez L; Gharahdaghi N; Ebrahimi S; Davies S; Loo PS; Szabo A; Williams E; Mukhopadhyay A; McLoughlin L; Irwin S; Travis S; Klenerman P; Bunn S; Cant AJ; Hambleton S; Uhlig HH; Doffinger R
    N Engl J Med; 2024 Aug; 391(5):434-441. PubMed ID: 39083772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal single-cell epitope and RNA-sequencing reveals the immunological impact of type 1 interferon autoantibodies in critical COVID-19: Anti-IFN antibodies in critical COVID-19 correlate with poor ISG response and upregulation of LAIR1 surface protein in PBMCs.
    van der Wijst MGP; Vazquez SE; Hartoularos GC; Bastard P; Grant T; Bueno R; Lee DS; Greenland JR; Sun Y; Perez R; Ogorodnikov A; Ward A; Mann SA; Lynch KL; Yun C; Havlir DV; Chamie G; Marquez C; Greenhouse B; Lionakis MS; Norris PJ; Dumont LJ; Kelly K; Zhang P; Zhang Q; Gervais A; Le Voyer T; Whatley A; Si Y; Byrne A; Combes AJ; Rao AA; Song YS; ; Fragiadakis GK; Kangelaris K; Calfee CS; Erle DJ; Hendrickson C; Krummel MF; Woodruff PG; Langelier CR; Casanova JL; Derisi JL; Anderson MS; Ye CJ
    bioRxiv; 2021 Mar; ():. PubMed ID: 33758859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.